A
71.97
1.58 (2.24%)
| Penutupan Terdahulu | 70.39 |
| Buka | 70.92 |
| Jumlah Dagangan | 321,517 |
| Purata Dagangan (3B) | 733,793 |
| Modal Pasaran | 4,917,007,360 |
| Harga / Buku (P/B) | 8.06 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Nov 2025 |
| EPS Cair (TTM) | -3.61 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.75% |
| Nisbah Semasa (MRQ) | 15.82 |
| Aliran Tunai Operasi (OCF TTM) | -188.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -120.81 M |
| Pulangan Atas Aset (ROA TTM) | -19.65% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.85% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Apogee Therapeutics, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.4
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.40 |
|
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 7.62% |
| % Dimiliki oleh Institusi | 137.71% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 115.00 (BTIG, 59.79%) | Beli |
| Median | 107.00 (48.67%) | |
| Rendah | 70.00 (RBC Capital, -2.74%) | Beli |
| Purata | 99.75 (38.60%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 54.45 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Craig-Hallum | 03 Nov 2025 | 109.00 (51.45%) | Beli | 54.35 |
| RBC Capital | 03 Nov 2025 | 70.00 (-2.74%) | Beli | 54.35 |
| 25 Sep 2025 | 60.00 (-16.63%) | Beli | 37.52 | |
| Mizuho | 21 Oct 2025 | 105.00 (45.89%) | Beli | 55.87 |
| BTIG | 09 Oct 2025 | 115.00 (59.79%) | Beli | 53.21 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HENDERSON JANE | - | 70.92 | -1,500 | -106,380 |
| Jumlah Keseluruhan Kuantiti Bersih | -1,500 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -106,380 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 70.92 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| HENDERSON JANE | Pegawai | 25 Nov 2025 | Jual automatik (-) | 1,500 | 70.92 | 106,380 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |